8,240 Clinical Drug Overviews
BRONCHITOL
Comprehensive clinical and safety monograph for BRONCHITOL (BRONCHITOL).
Mucolytic
BRONCHO SALINE
Comprehensive clinical and safety monograph for BRONCHO SALINE (BRONCHO SALINE).
Saline Solution
BRONITIN MIST
Comprehensive clinical and safety monograph for BRONITIN MIST (BRONITIN MIST).
Bronchodilator
BRONKAID MIST
Comprehensive clinical and safety monograph for BRONKAID MIST (BRONKAID MIST).
BRONKODYL
Comprehensive clinical and safety monograph for BRONKODYL (BRONKODYL).
BRONKOMETER
Comprehensive clinical and safety monograph for BRONKOMETER (BRONKOMETER).
BRONKOSOL
Comprehensive clinical and safety monograph for BRONKOSOL (BRONKOSOL).
BROVANA
Comprehensive clinical and safety monograph for BROVANA (BROVANA).
BRUKINSA
Comprehensive clinical and safety monograph for BRUKINSA (BRUKINSA).
Antineoplastic BTK Inhibitor
BRYHALI
Comprehensive clinical and safety monograph for BRYHALI (BRYHALI).
Topical Corticosteroid
BRYNOVIN
Comprehensive clinical and safety monograph for BRYNOVIN (BRYNOVIN).
Opioid Partial Agonist
BRYREL
Comprehensive clinical and safety monograph for BRYREL (BRYREL).
BSS
Comprehensive clinical and safety monograph for BSS (BSS).
Ophthalmic Irrigating Solution
BSS PLUS
Comprehensive clinical and safety monograph for BSS PLUS (BSS PLUS).
BUCAPSOL
Comprehensive clinical and safety monograph for BUCAPSOL (BUCAPSOL).
Topical Analgesic
BUCET
Comprehensive clinical and safety monograph for BUCET (BUCET).
Barbiturate Combination Analgesic
BUCLADIN-S
Comprehensive clinical and safety monograph for BUCLADIN-S (BUCLADIN-S).
Disease-Modifying Antirheumatic Drug
BUDESONIDE
No significant drug interactions Systemic absorption can occur with extensive use.
Inhaled Corticosteroid
Budesonide (Inhaled)
Inhaled corticosteroid (ICS) for persistent asthma. The most studied ICS in pregnancy; large registry data (>2,500 exposures) confirm no increase in congenital malformations. Preferred ICS to initiate in pregnancy due to available safety data, though other ICS are considered acceptable. Systemic absorption from inhaled use is minimal. Uncontrolled asthma poses greater risk than ICS treatment.
BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE
Other adrenergic drugs can have additive cardiovascular effects Can cause paradoxical bronchospasm and increase the risk of asthma-related death.
LABA
BUMETANIDE
Other ototoxic drugs may increase risk of hearing loss Indomethacin may reduce the diuretic effect Profound diuresis and electrolyte depletion can occur.
Loop Diuretic
BUMEX
Comprehensive clinical and safety monograph for BUMEX (BUMEX).
BUNAVAIL
Comprehensive clinical and safety monograph for BUNAVAIL (BUNAVAIL).
Opioid Partial Agonist Combination
BUPHENYL
Comprehensive clinical and safety monograph for BUPHENYL (BUPHENYL).
Ammonia-Reducing Agent
BUPIVACAINE HYDROCHLORIDE
Comprehensive clinical and safety monograph for BUPIVACAINE HYDROCHLORIDE (BUPIVACAINE HYDROCHLORIDE).
Local Anesthetic
BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE
Beta-blockers may antagonize cardiac effects and cause severe hypertension Can cause angina and arrhythmias in patients with heart disease.
Alpha/Beta Agonist
BUPIVACAINE HYDROCHLORIDE KIT
Comprehensive clinical and safety monograph for BUPIVACAINE HYDROCHLORIDE KIT (BUPIVACAINE HYDROCHLORIDE KIT).
BUPIVACAINE HYDROCHLORIDE PRESERVATIVE FREE
Comprehensive clinical and safety monograph for BUPIVACAINE HYDROCHLORIDE PRESERVATIVE FREE (BUPIVACAINE HYDROCHLORIDE PRESERVATIVE FREE).
BUPIVACAINE LIPOSOME
Comprehensive clinical and safety monograph for BUPIVACAINE LIPOSOME (BUPIVACAINE LIPOSOME).
BUPRENEX
Comprehensive clinical and safety monograph for BUPRENEX (BUPRENEX).
BUPRENORPHINE
Benzodiazepines and other CNS depressants increase risk of respiratory depression Can precipitate withdrawal in patients dependent on other opioids.
BUPRENORPHINE HYDROCHLORIDE
BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE
No significant drug interactions Can precipitate acute withdrawal in patients dependent on opioids.
Opioid Antagonist
BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE
BUPROPION HYDROBROMIDE
MAOIs can increase risk of hypertensive episodes Lowers seizure threshold in a dose-dependent manner.
Atypical Antidepressant
BUPROPION HYDROCHLORIDE
BUSPAR
Comprehensive clinical and safety monograph for BUSPAR (BUSPAR).
Anxiolytic
BUSPIRONE HYDROCHLORIDE
MAOIs may increase blood pressure Use cautiously with other CNS depressants Not effective for benzodiazepine withdrawal.
BUSULFAN
Comprehensive clinical and safety monograph for BUSULFAN (BUSULFAN).
Alkylating Agent
BUSULFEX
Comprehensive clinical and safety monograph for BUSULFEX (BUSULFEX).
BUTABARB
Comprehensive clinical and safety monograph for BUTABARB (BUTABARB).
Barbiturate
BUTABARBITAL
Comprehensive clinical and safety monograph for BUTABARBITAL (BUTABARBITAL).
BUTABARBITAL SODIUM
Comprehensive clinical and safety monograph for BUTABARBITAL SODIUM (BUTABARBITAL SODIUM).
BUTALAN
Comprehensive clinical and safety monograph for BUTALAN (BUTALAN).
BUTALBITAL AND ACETAMINOPHEN
Comprehensive clinical and safety monograph for BUTALBITAL AND ACETAMINOPHEN (BUTALBITAL AND ACETAMINOPHEN).
Barbiturate Combination
BUTALBITAL, ACETAMINOPHEN AND CAFFEINE
Comprehensive clinical and safety monograph for BUTALBITAL, ACETAMINOPHEN AND CAFFEINE (BUTALBITAL, ACETAMINOPHEN AND CAFFEINE).
BUTALBITAL, ACETAMINOPHEN, CAFFEINE AND CODEINE PHOSPHATE
CNS depressants including alcohol and benzodiazepines increase sedation risk Life-threatening respiratory depression may occur especially in CYP2D6 ultra-rapid metabolizers.
Barbiturate + Analgesic
BUTALBITAL, ASPIRIN AND CAFFEINE
Anticoagulants like warfarin increase bleeding risk Concomitant use with other NSAIDs increases GI toxicity Risk of Reye's syndrome in children and teenagers with viral infections.
NSAID / Antiplatelet
BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE
Opioid Agonist
BUTAPAP
Comprehensive clinical and safety monograph for BUTAPAP (BUTAPAP).
Showing 1001 - 1050 of 8245
